BB Pureos Bioventures

Investor type

VC / CVC

Last fund created

2020

AUM

-

Location

Switzerland

$0-1 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Profile

STRATEGY Pureos Bioventures invests venture capital in private innovative drug development companies, with an emphasis on the next generation of biological drugs and drug formats. We strive to impact patients’ lives by advancing innovative treatments for severe diseases. PORTFOLIO Our companies are developing innovative therapeutics for severe diseases and contitions. We are backing great teams with development programs that make a true difference for patients. TEAM We are career venture capitalists, biotech founders, former pharma and biotech executives, research scientists, medical doctors, and experienced drug developers. What unites us is the passion for biotech start-ups, innovation and the quest for new and better medicines.

Industry

Healthcare Services HealthTech Biotechnology Pharmaceuticals

Region of investment

North America Europe

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
BnLq69FQAk3IeahZ Managing Partner
Managing Partner
avatar
BnLq69FQAk3IeahZ Venture Partner
Venture Partner
avatar
BnLq69FQAk3IeahZ Analyst
Analyst
avatar
BnLq69FQAk3IeahZ Managing Partner
Managing Partner
avatar
BnLq69FQAk3IeahZ Advisor
Advisor
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!